BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking

BMC Urology

Volumn 5, Issue , 2005, Pages

  Chen, Fanghong ^a   Zhang, Guangjian ^a   Iwamoto, Yoshiki ^a   See, William A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ARGINYLGLYCYLASPARTYLSERINE; BCG VACCINE; CASPASE; CASPASE 3; DNA; INTEGRIN; PEPTIDE; VERY LATE ACTIVATION ANTIGEN 5;

APOPTOSIS; ARTICLE; ASSAY; BINDING SITE; BLADDER CARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; CELL COUNT; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CROSS LINKING; CYTOSTASIS; DNA DETERMINATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INHIBITION KINETICS; MEASUREMENT; NITROBLUE TETRAZOLIUM TEST; UROGENITAL TRACT TUMOR;

ADJUVANTS, IMMUNOLOGIC; APOPTOSIS; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; CELL CYCLE; CELL LINE, TUMOR; HUMANS; INTEGRIN ALPHA5BETA1;

EID: 23044445886     PISSN: 14712490     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-5-8     Document Type: Article

References (18)

1. Malkowicz SB: Intravesical therapy for superficial bladder cancer. Semin Urol Oncol 2000, 18(4):280-8.
2. Bohle A, Jocham D, Bock PR: Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J Urol 2003, 169(1):90-5.
3. Sylvester RJ, van der MEIJDEN AP, Lamm DL: Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 2002, 168(5):1964-70.
4. Bohle A, Brandau S: Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer. J Urol 2003, 170(3):964-9.
5. Pryor K, Stricker P, Russell P, et al.: Antiproliferative effects of bacillus Calmette-Guerin and interferon alpha 2b on human bladder cancer cells in vitro. Cancer Immunol Immunother 1995,41(5):309-16.
6. Seow SW, Rahmat JN, Mohamed AA, et al.: Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium Bovis (bacillus Calmette-Guerin). J Urol 2002,168(5):2236-9.
7. Liu BC, Redwood SM, Weiss RE, et al.: Bacillus Calmette-Guerin abrogates in vitro invasion and motility of human bladder tumor cells via fibronectin interaction. J Urol 1992,148(3):900-5.
8. Chen F, Zhang G, Iwamoto Y, See WA: Bacillus Calmette-Guerin initiates intracellular signaling in a transitional carcinoma cell line by cross-linking α5β1 integrin. J Urol 2003, 170(2 Pt 1):605-10.
9. Chen F-H, Crist SA, Zhang G-J: Interleukin-6 production by human bladder tumor cell lines is upregulated by BCG through NF-κb and AP-1 via an immediate early pathway. J Urol 2002, 168:786-797.
10. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
11. Schultz DR, Harrington WJ Jr: Apoptosis: programmed cell death at a molecular level. Semin Arthritis Rheum 2003,32(6):345-69.
12. Cheng DL, Shu WP, Choi JC, Margolis EJ, Droller MJ, Liu BC: Bacillus Calmette-Guerin interacts with the carboxyl-terminal heparin-binding domain of fibronectin: implications for BCG-mediated anti-tumor activity. J Urol 1994,152(4):1275-80.
13. Zhao W, Schorey JS, Bong-Mastek M, Ritchey J, Brown EJ, Ratliff TL: Role of a bacillus Calmette-Guerin fibronectin attachment protein in BCG-induced anti-tumor activity. Int J Cancer 2000,86(1):83-8.
14. Kavoussi LR, Brown EJ, Ritchey JK, Ratliff TL: Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response. J Clin Invest 1990, 85(1):62-7.
15. Sasaki A, Kudoh S, Mori K, et al.: Are BCG effects against urinary bladder carcinoma cell line T24 correlated with apoptosis in vitro. Urologia Internationalis 1997, 59(3):142-8.
16. Pook SH, Esuvaranathan K, Mahendran R: N-acetylcysteine augments the cellular redox changes and cytotoxic activity of internalized mycobacterium bovis in human bladder cancer cells. J Urol 2002, 168(2):780-5.
17. Jansson OT, Morcos E, Brundin L, Lundberg JO, Adolfsson J, Soderhall M, Wiklund NP: The role of nitric oxide in bacillus Calmette-Guerin mediated anti-tumour effects in human bladder cancer. Br J Cancer 1998, 78(5):588-92.
18. Zhang GJ, Chen FH, Xu Y, Cao Y, Crist S, McKerrow A, Iwamoto Y, See WA: Autocrine overexpression of fibronectin by human transitional carcinoma cells impairs BCG adherence and signaling. J Urol 2004, 172(4):1496-1500.